Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology
Clinical Trials: Metastatic Cancer
A listing of clinical trials currently looking for volunteers to enroll in Metastatic Cancer studies. Click on the closest city to find more detailed information on a research study in your area.
Arizona
Scottsdale : TGen Clinical Research Services at Scottsdale Healthcare
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Tucson : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
California
Duarte : City of Hope Updated
A Phase 1 Study of ABT-888 in Combination with Carboplatin and Gemcitabine in Subjects with Advanced Solid Tumors
Encinitas : Pacific Oncology & Hematology Associates
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
Glendale : Glendale Adventist Medical Center
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
Highland : Beaver Medical Group
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
La Verne : Wilshire Oncology Medical Group
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
Los Angeles : UCLA
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
San Diego : Sharp Memorial Hospital
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
View More »
Encinitas : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Fullerton : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Greenbrae : Marin Cancer Care
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
La Jolla : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Los Angeles : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Rancho Mirage : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Redondo Beach : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Santa Maria : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Santa Monica : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY3007113 in Patients With Advanced Cancer
Connecticut
New Haven : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Florida
Georgia
Savannah : Memorial Health University Medical Center
Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone SWOG S0622
Illinois
Elgin : Sherman Health
Metastatic
ECOG E3108: Ph II PFS with CYP2D6 activity treated with Tamoxifen ER/PR +, Pre/post menopausal, Stg III locally advanced or metastatic.
Harvey : Ingalls Memorial Hospital
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
Harvey : Ingalls Memorial Hospital
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
Skokie : Orchard Research
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
Skokie : Clintell, Inc.
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
View More »
Chicago : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Harvey : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Quincy : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Maryland
Salisbury : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Massachusetts
Boston : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Michigan
Detriot : Karmanos Cancer Institute
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Detroit : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Grand Rapids : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Minnesota
Minneapolis : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Nebraska
Omaha : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
New Hampshire
Lebanon : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
New York
Manhasset : Biomedical Research Alliance of New York
Metastatic Cancer to the Brain - Adults
New York : Herbert Irving Comprehensive Cancer Center
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
View More »
Bronx : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Great Neck : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
New York : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
New York : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
North Carolina
Charlotte : Presbyterian Hospital Center for Cancer Research
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
Durham : Duke University Health System
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
Winston-Salem : Piedmont Hematology Oncology
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
View More »
Durham : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Durham : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Goldsboro : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Huntersville : Carolina BioOncology Institute
Isolation and Culture of Circulating Tumor Cells From Peripheral Blood
North Dakota
Bismarck : St. Alexius Medical Center
A research study for patients with metastatic pancreatic cancer. You may qualify for this study if you have a diagnosis of an advanced type of pancreatic cancer for which standard therapy is not optimal.
Ohio
Middletown : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Oregon
Bend : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Rhode Island
Providence : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
South Carolina
Greer : Cancer Center of the Carolinas
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
View More »
Charleston : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Tennessee
Memphis : Family Cancer Center
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
View More »
Knoxville : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Nashville : Sarah Cannon Research Institute
A Study of ARRY-382 in Patients With Selected Advanced or Metastatic Cancers
Texas
Washington
Spokane Valley : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Australia
Bentleigh East : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Kogarah : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Kurralta Park : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Parkville : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
South Brisbane : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
View More »
Woodville South : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Austria
Innsbruck : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Salzburg : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Steyr : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Wien : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Belgium
Bruxelles : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Charleroi : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Edegem : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Gent : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Leuven : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
View More »
Leuven : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Libramont : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Liege : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Wilrijk : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Brazil
Curitba : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Curitba : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
ItajaÃ- : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Itajaí : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Porto Alegre : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
View More »
Porto Alegre : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
São Paulo : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Salvador : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Canada
Oshawa : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Ottawa : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Québec : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Quebec : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Québec : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
View More »
Toronto : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Vancouver : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Czech Republic
Brno : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Hradec Kralove : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Olomouc : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Praha 2 : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Praha 5 : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Denmark
Aalborg : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Herlev : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Odense : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Finland
HUS : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Lahti : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Tampere : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Turku : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
France
Besançon Cedex : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Besançon Cedex : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Bordeaux : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Brest cedex : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Caen Cedex 05 : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
View More »
Clermont Ferrand Cedex 1 : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
La Roche Sur Yon Cedex 9 : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Limoges Cedex : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Marseille : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Montpellier Cedex 5 : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Nantes Cedex 2 : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Pessac Cedex : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Pierre Benite Cedex : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Toulouse : Research Site
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Villejuif cedex : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Germany
Berlin : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Dresden : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Halle (Saale) : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Münster : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Mainz : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
View More »
Mannheim : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Marburg : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Münster : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Villingen-Schwenningen : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Greece
Athens : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Heraklion : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Patra : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Thessaloniki : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Hong Kong
Kowloon : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Sha Tin : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Tuen Mun : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Hungary
Budapest : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Debrecen : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Gyor : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Miskolc : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Italy
Bologna : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Firenze (FI) : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Genova : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Messina : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Milano : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
View More »
Napoli : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Padova : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Roma : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
San Giovanni Rotondo (FG) : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Japan
Kashiwa : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Mitaka-city : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Nagoya-city : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Osaka : Research Site
Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients
Sunto-gun : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
View More »
Tokyo : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Yokohama-city : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Korea, Republic of
Seoul : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Lithuania
Kaunas : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Vilnius : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Netherlands
Amsterdam : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Eindhoven : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Groningen : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Leiden : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Poland
Gdansk : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Konin : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Lodz : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Poznan : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Warszawa : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
View More »
Warszawa : Research Site
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Portugal
Barreiro : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Lisboa : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Porto : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Romania
Cluj Napoca : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Cluj-Napoca : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Russian Federation
Chelyabinsk : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Moscow : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Saint Petersburg : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Samara : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Serbia
Belgrade : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Sremska Kamenica : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Slovakia
Bardejov : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Bratislava : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Kosice : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Nitra : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Poprad : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Slovenia
Ljubljana : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Spain
A Coruña : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
A Coruña : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Badalona : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Badalona : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Barcelona : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
View More »
Barcelona : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Elche : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Elche : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Madrid : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Santander : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Valencia : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Sweden
Eskilstuna : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Linköping : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Linköping : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Uppsala : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Switzerland
Basel : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Geneva 14 : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Winterthur : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Taiwan
Gueishan Township : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Niaosong Township : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Taipei City : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
United Kingdom
Aberdeen : Aberdeen Royal Infirmary
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
Belfast, N. Ireland : Cancer Centre
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
Bournemouth : Royal Bournemouth Hospital
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
Bristol : Bristol Royal Infirmary
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
Dorchester, Dorset : Dorset County Hospital
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
London : Guy's Hospital
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
Northwood : Mount Vernon Hospital
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
Romford : Queen's Hospital
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
Sutton : Royal Marsden Hospital
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
Whitchurch, Cardiff : Velindre Hospital
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer.
View More »
Belfast : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Birmingham : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Cottingham : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Leicester : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Manchester : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Northampton : Research Site
GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
